The LevoCept Intrauterine Contraceptive will soon be in a clinical study in the United States. It is limited by United States Federal Law to Investigational Use.
LevoCept is a levonorgestrel releasing intrauterine device intended to prevent pregnancy. LevoCept will soon be undergoing a Phase 2 Clinical Trial in the United States.
The LevoCept Difference
Properties of LevoCept intended to be investigated in the upcoming clinical study include:
- Flexible shape memory frame
- 52 mg of levonorgestrel
- Smaller insertion profile
- Pre-loaded Introducer
- Pre-trimmed retrieval thread
Learn More About LevoCept
CAUTION: New Drug- Limited by Federal Law to Investigational Use.